4.7 Article

Essential Role of CD11a in CD8(+) T-Cell Accumulation and Activation in Adipose Tissue

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.113.302077

关键词

adipose tissue; inflammation; insulin resistance; obesity

资金

  1. National Institutes of Health [HL098839, DK078847]
  2. United States Department of Agriculture/Agricultural Research Service (USDA/ARS) [6250-51000-055-30]
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098839] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080874, R01DK078847] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129, P20GM103527] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Objective-T cells, particularly CD8(+) T cells, are major participants in obesity-linked adipose tissue (AT) inflammation. We examined the mechanisms of CD8(+) T-cell accumulation and activation in AT and the role of CD11a, a beta 2 integrin. Approach and Results-CD8(+) T cells in AT of obese mice showed activated phenotypes with increased proliferation and interferon-gamma expression. In vitro, CD8(+) T cells from mouse AT displayed increased interferon-gamma expression and proliferation to stimulation with interleukin-12 and interleukin-18, which were increased in obese AT. CD11a was upregulated in CD8(+) T cells in obese mice. Ablation of CD11a in obese mice dramatically reduced T-cell accumulation, activation, and proliferation in AT. Adoptive transfer showed that CD8(+) T cells from wild-type mice, but not from CD11a-deficient mice, infiltrated into AT of recipient obese wild-type mice. CD11a deficiency also reduced tumor necrosis factor-alpha-producing and interleukin-12-producing macrophages in AT and improved insulin resistance. Conclusions-Combined action of cytokines in obese AT induces proliferative response of CD8(+) T cells locally, which, along with increased infiltration, contributes to CD8(+) T-cell accumulation and activation in AT. CD11a plays a crucial role in AT inflammation by participating in T-cell infiltration and activation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Peripheral Vascular Disease

Renin: Measurements, Correlates, and Associations With Long-Term Adverse Kidney Outcomes

Matthew F. Blum, Jingsha Chen, Aditya Surapaneni, Stephen T. Turner, Christie M. Ballantyne, Paul A. Welling, Anna Koettgen, Josef Coresh, Deidra C. Crews, Morgan E. Grams

Summary: This study investigated the association of renin with adverse kidney outcomes and compared different measurement strategies. The results showed that renin levels measured by SomaScan modified nucleotide aptamer assay were predictive of chronic kidney disease, end-stage kidney disease, and mortality. The SomaScan measurement was moderately correlated with plasma renin activity and highly correlated with renin level from Olink.

AMERICAN JOURNAL OF HYPERTENSION (2023)

Article Urology & Nephrology

Testican-2 Is Associated with Reduced Risk of Incident ESKD

Donghai Wen, Linda Zhou, Zihe Zheng, Aditya Surapaneni, Christie M. Ballantyne, Ron C. Hoogeveen, Michael G. Shlipak, Sushrut S. Waikar, Ramachandran S. Vasan, Paul L. Kimmel, Ruth F. Dubin, Rajat Deo, Harold I. Feldman, Peter Ganz, Josef Coresh, Morgan E. Grams, Eugene P. Rhee

Summary: Testican-2, a protein released into circulation by the kidneys, is positively correlated with eGFR and eGFR slope. However, it is unknown whether higher testican-2 levels are associated with lower risk of ESKD.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Review Medical Laboratory Technology

Clonal hematopoiesis of indeterminate potential and cardiovascular disease

Seyedmohammad Saadatagah, Christie M. Ballantyne

Summary: Age is a crucial risk factor for cardiovascular disease, as genetic mutations occur with aging, leading to somatic mosaicism. Clonal hematopoiesis resulting from somatic mutations, known as CHIP, has been associated with an increased risk of cardiovascular disease. Recent advances in exome-sequencing projects have enabled the study of CHIP frequency, gene-specific analyses, and potential therapeutic implications for preventing cardiovascular disease.

TRANSLATIONAL RESEARCH (2023)

Article Pharmacology & Pharmacy

Severe hypercholesterolemia in a patient with very low albumin and normal renal function

Mini G. Varughese, Matthew R. Deshotels, Lilei Zhang, Christie M. Ballantyne

Summary: A 20-year-old male presented with severe elevation in low-density lipoprotein cholesterol (LDL-C) and was initially tested negative for familial hypercholesterolemia. Further genetic testing revealed homozygous variants in the ALB gene, indicating congenital analbuminemia (CAA) as the cause of severe hyperlipidemia. CAA is a rare autosomal recessive disorder with a frequency of about 1:1,000,000. Pathological variants in the ALB gene disrupt albumin synthesis and can lead to gross hyperlipidemia and hypercholesterolemia. Early diagnosis through genetic examination is crucial for initiating lipid-lowering treatments and preventing premature coronary artery disease.

JOURNAL OF CLINICAL LIPIDOLOGY (2023)

Article Biochemical Research Methods

A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study

Bruno Bohn, Pamela L. Lutsey, Weihong Tang, James S. Pankow, Faye L. Norby, Bing Yu, Christie M. Ballantyne, Eric A. Whitsel, Kunihiro Matsushita, Ryan T. Demmer

Summary: This study compared the proteome of statin users and nonusers and found differences in proteins unrelated to lipid metabolism. Further investigation into these differences may help elucidate the pleiotropic effects of statins.

JOURNAL OF PROTEOMICS (2023)

Article Biochemistry & Molecular Biology

Plasma proteins related to inflammatory diet predict future cognitive impairment

Michael R. R. Duggan, Lauren Butler, Zhongsheng Peng, Gulzar N. N. Daya, Abhay Moghekar, Yang An, Stephen R. R. Rapp, Kathleen M. M. Hayden, Aladdin H. H. Shadyab, Ginny Natale, Longjian Liu, Linda Snetselaar, Ruin Moaddel, Casey M. M. Rebholz, Kevin Sullivan, Christie M. M. Ballantyne, Susan M. M. Resnick, Luigi Ferrucci, Keenan A. A. Walker

Summary: Dysregulation of the immune system and inflammatory dietary patterns may increase the risk for cognitive decline. Proteomic assays of plasma samples identified a group of proteins linked to future cognitive impairment, as well as associations with dementia risk and biomarkers of Alzheimer's disease and neurodegeneration.

MOLECULAR PSYCHIATRY (2023)

Letter Cardiac & Cardiovascular Systems

Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease

Salim S. S. Virani, David J. J. Ramsey, Dax Westerman, Mark K. K. Kuebeler, Liang Chen, Julia M. M. Akeroyd, Glenn T. T. Gobbel, Christie M. M. Ballantyne, Laura A. A. Petersen, Alexander Turchin, Michael E. E. Matheny

CIRCULATION (2023)

Letter Cardiac & Cardiovascular Systems

Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart Disease

Yiyi Zhang, Jacqueline S. Dron, Brandon K. Bellows, Amit V. Khera, Junxiu Liu, Pallavi P. Balte, Elizabeth C. Oelsner, Sami Samir Amr, Matthew S. Lebo, Anna Nagy, Gina M. Peloso, Pradeep Natarajan, Jerome I. Rotter, Cristen Willer, Eric Boerwinkle, Christie M. Ballantyne, Pamela L. Lutsey, Myriam Fornage, Donald M. Lloyd-Jones, Lifang Hou, Bruce M. Psaty, Joshua C. Bis, James S. Floyd, Ramachandran S. Vasan, Nancy L. Heard-Costa, April P. Carson, Michael E. Hall, Stephen S. Rich, Xiuqing Guo, Dhruv S. Kazi, Sarah D. de Ferranti, Andrew E. Moran

CIRCULATION (2023)

Article Cardiac & Cardiovascular Systems

Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

Nicolas Girerd, Daniel Levy, Kevin Duarte, Joao Pedro Ferreira, Christie Ballantyne, Timothy Collier, Anne Pizard, Jens Bjoerkman, Javed Butler, Andrew Clark, John G. Cleland, Christian Delles, Javier Diez, Arantxa Gonzalez, Mark Hazebroek, Jennifer Ho, Anne-Cecile Huby, Shih-Jen Hwang, Roberto Latini, Beatrice Mariottoni, Alexandre Mebazaa, Pierpaolo Pellicori, Naveed Sattar, Peter Sever, Jan A. Staessen, Job Verdonschot, Stephane Heymans, Patrick Rossignol, Faiez Zannad

Summary: This study identified protein biomarkers associated with new-onset heart failure in three independent cohorts. The inclusion of these biomarkers in addition to clinical risk factors improved the prediction of heart failure risk. The B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide were found to be particularly relevant in predicting heart failure.

CIRCULATION-HEART FAILURE (2023)

Article Endocrinology & Metabolism

Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study

Suzanne V. Arnold, James A. de Lemos, Luke Zheng, Robert S. Rosenson, Christie M. Ballantyne, Shushama Alam, Deepak L. Bhatt, Christopher P. Cannon, Mikhail Kosiborod, GOULD Investigators

Summary: The study aimed to examine the improvement in the use of optimal medical therapy (OMT) for patients with atherosclerotic cardiovascular disease (ASCVD) and diabetes. The study found that the use of secondary prevention in US patients with ASCVD and diabetes was suboptimal, with minimal improvement over time.

DIABETES OBESITY & METABOLISM (2023)

Article Pharmacology & Pharmacy

Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial

Paul M. Ridker, Lei Lei, Kausik K. Ray, Christie M. Ballantyne, Gary Bradwin, Nader Rifai

Summary: Bempedoic acid (BA) reduces hsCRP and LDL-C levels in patients with atherosclerotic disease and/or familial hypercholesterolemia. It also shows potential anti-inflammatory effects and has similar lipid-lowering and inflammation-inhibiting properties to statin therapy.

JOURNAL OF CLINICAL LIPIDOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study

Xiaoming Jia, Leo Buckley, Caroline Sun, Mahmoud Al Rifai, Bing Yu, Vijay Nambi, Salim S. Virani, Elizabeth Selvin, Kunihiro Matsushita, Ron C. Hoogeveen, Josef Coresh, Amil M. Shah, Christie M. Ballantyne

Summary: Higher levels of interleukin-6 and interleukin-18 in older adults are associated with an increased risk of global cardiovascular disease (including coronary heart disease, stroke, and heart failure) and death. The association between interleukin-6 and global cardiovascular disease is stronger than that for interleukin-18, and remains significant even after adjustments for other biomarkers.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Growth Differentiation Factor 15 and Risk of Bleeding Events: The Atherosclerosis Risk in Communities Study

Lena Mathews, Xiao Hu, Ning Ding, Junichi Ishigami, Mahmoud Al Rifai, Ron C. C. Hoogeveen, Josef Coresh, Christie M. M. Ballantyne, Elizabeth Selvin, Kunihiro Matsushita

Summary: A study on 9205 participants from the ARIC study found that higher levels of GDF15 protein were associated with bleeding events and improved the prediction of bleeding risk in individuals without cardiovascular disease.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry

Marina Cuchel, Paul C. Lee, Lisa C. Hudgins, P. Barton Duell, Zahid Ahmad, Seth J. Baum, MacRae F. Linton, Sarah D. de Ferranti, Christie M. Ballantyne, John A. Larry, Linda C. Hemphill, Iris Kindt, Samuel S. Gidding, Seth S. Martin, Patrick M. Moriarty, Paul P. Thompson, James A. Underberg, John R. Guyton, Rolf L. Andersen, David J. Whellan, Irwin Benuck, John P. Kane, Kelly Myers, William Howard, David Staszak, Allison Jamison, Mary C. Card, Mafalda Bourbon, Joana R. Chora, Daniel J. Rader, Joshua W. Knowles, Katherine Wilemon, Mary P. McGowan

Summary: This study investigated the diagnosis and treatment of HoFH in the United States and found a low diagnosis rate and low treatment rate, highlighting the need for enhanced screening and treatment to reduce the burden of the disease.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT

Brian Olshansky, Deepak L. L. Bhatt, Michael Miller, Ph. Gabriel Steg, Eliot A. A. Brinton, Terry A. A. Jacobson, Steven B. B. Ketchum, Ralph T. T. Doyle Jr, Rebecca A. A. Juliano, Lixia Jiao, Peter R. R. Kowey, James A. A. Reiffel, Jean-Claude Tardif, Christie M. M. Ballantyne, Mina K. K. Chung

Summary: In the REDUCE-IT study, icosapent ethyl (IPE) reduced cardiovascular events but was associated with increased atrial fibrillation/atrial flutter (AF) hospitalization. The study analyzed the relationships between IPE and outcomes in patients with or without prior AF and with or without in-study AF hospitalization. Overall, in-study AF hospitalization rates were higher in patients with prior AF, especially in those randomized to IPE. Serious bleeding rates also trended higher in these patients. However, patients with prior AF or in-study AF hospitalization showed consistent risk reductions in cardiovascular events with IPE.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

暂无数据